Your browser doesn't support javascript.
loading
Zero-length crosslinking procedure with the use of active esters.
Grabarek, Z; Gergely, J.
Afiliación
  • Grabarek Z; Department of Muscle Research, Harvard Medical School, Massachusetts.
Anal Biochem ; 185(1): 131-5, 1990 Feb 15.
Article en En | MEDLINE | ID: mdl-2344038
ABSTRACT
A two-step zero-length crosslinking procedure for studying protein-protein complexes has been developed. One component of a complex is briefly incubated with 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) in the presence of N-hydroxysuccinimide resulting in the conversion of some of the protein carboxyls into succinimidyl esters. The reaction is stopped by addition of beta-mercaptoethanol and other interacting proteins are then added. Crosslinking arises from substitution of lysine epsilon-amino groups of these proteins for the succinimidyl moieties during a 1- to 2-h incubation period. The advantage of this method versus one-step zero-length crosslinking is that only one component of the complex is exposed to the crosslinker, which eliminates complications arising from the formation of crosslinks among several proteins of a multicomponent complex. Furthermore, crosslinks can be formed even in the presence of reagents, such as dithiothreitol and EDTA, that would interfere with direct crosslinking with EDC.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas / Reactivos de Enlaces Cruzados Límite: Animals Idioma: En Revista: Anal Biochem Año: 1990 Tipo del documento: Article
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas / Reactivos de Enlaces Cruzados Límite: Animals Idioma: En Revista: Anal Biochem Año: 1990 Tipo del documento: Article
...